[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356350-105":59,"doc-detail-356350-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","noninvasive-diagnosis-of-colorectal-adenoma-the-emerging-potential-of-blood-based-biomarkers","Noninvasive diagnosis of colorectal adenoma - The emerging potential of blood-based biomarkers","","Colorectal cancer is a major global health challenge, with most cases arising from colorectal adenomas along the adenoma-carcinoma sequence, making early detection at the adenoma stage critical. Colonoscopy-based screening is invasive and suffers from limited compliance, creating demand for efficient noninvasive alternatives. Blood-based biomarkers offer accessible, reproducible options for early diagnosis. Multiomics advances in proteomics, metabolomics, transcriptomics, and epigenomics have enabled diverse plasma/serum biomarkers, and integrating these data may improve sensitivity and specificity for adenoma detection and colorectal cancer risk stratification.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/noninvasive-diagnosis-of-colorectal-adenoma-the-emerging-potential-of-blood-based-biomarkers/356350/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/noninvasive-diagnosis-of-colorectal-adenoma-the-emerging-potential-of-blood-based-biomarkers/356350.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early diagnosis of colorectal adenoma important?","Question",{"text":112,"@type":113},"Most colorectal cancers develop through an adenoma-carcinoma sequence, beginning with colorectal adenomas. Detecting and intervening at the adenoma stage helps reduce the global burden of colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is the main limitation of conventional CRC screening methods mentioned in the document?",{"text":117,"@type":113},"Conventional screening such as colonoscopy is invasive and has poor compliance. This drives the urgent need for efficient, noninvasive diagnostic alternatives.",{"name":119,"@type":110,"acceptedAnswer":120},"How do blood-based biomarkers support noninvasive screening?",{"text":121,"@type":113},"Blood-based biomarkers are highlighted for their accessibility and reproducibility, enabling early detection. Multiomics approaches identify many plasma- and serum-derived biomarker types that can enhance adenoma detection.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356350,1790327322,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","| W | J | G | World Journal of\u003Cbr>Gastroenterology |\n| --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Gastroenterol 2026 February 21; 32(7): 114538  \nDOI: 10.3748/wjg.v32.i7.114538 ISSN 1007-9327 (print) ISSN 2219-2840 (online)  \nREVIEW  \nNoninvasive diagnosis of colorectal adenoma: The emerging potential of blood-based biomarkers  \nCen-Yi Qi, Ran Wang, Jia-Wei Wang, Guo-Liang Ye, Ping Yang, Yu-Ping Zhou  \nSpecialty type: Gastroenterology and hepatology  \nProvenance and peer review:  \nUnsolicited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s classification Scientific Quality: Grade B, Grade B, Grade B  \nNovelty: Grade B, Grade B, Grade B  \nCreativity or Innovation: Grade B, Grade B, Grade C  \nScientific Significance: Grade B, Grade B, Grade B  \nP-Reviewer: Bagus BI, Associate Professor, Indonesia; Osera S, MD, Chief Physician, Japan  \nReceived: September 23, 2025  \nRevised: December 1, 2025  \nAccepted: December 29, 2025  \nPublished online: February 21, 2026  \nProcessing time: 137 Days and 4.9 Hours  \nCen-Yi Qi, Ran Wang, Jia-Wei Wang, Guo-Liang Ye, Department of Gastroenterology, The First Affiliated Hospital of Ningbo University, Ningbo 315020, Zhejiang Province, China  \nCen-Yi Qi, Ran Wang, Jia-Wei Wang, Health Science Center, Ningbo University, Ningbo 315211, Zhejiang Province, China  \nGuo-Liang Ye, Yu-Ping Zhou, Institute of Digestive Disease, Institute of Digestive Disease of Ningbo University, Ningbo 315020, Zhejiang Province, China  \nGuo-Liang Ye, Yu-Ping Zhou, Laboratory of Translational Medicine Research on Gastroenterology and Hepatology, Ningbo Key Laboratory, Ningbo 315020, Zhejiang Province, China  \nPing Yang, Department of Geriatric Medicine, The First Affiliated Hospital of Ningbo University, Ningbo 315020, Zhejiang Province, China  \nYu-Ping Zhou, Department of Traditional Chinese Medicine, The First Affiliated Hospital of  \nNingbo University, Ningbo 315020, Zhejiang Province, China Co-corresponding authors: Ping Yang and Yu-Ping Zhou.  \nCorresponding author: Yu-Ping Zhou, PhD, Doctor, Department of Traditional Chinese Medicine, The First Affiliated Hospital of Ningbo University, No. 247 Renmin Road, Jiangbei District, Ningbo 315020, Zhejiang Province, [China.](China. fyzhouyuping@nbu.edu.cn)[ fyzhouyuping@nbu.edu.cn](China. fyzhouyuping@nbu.edu.cn)  \nAbstract  \nColorectal cancer (CRC) is the third most commonly diagnosed cancer and the second leading cause of cancer-related death globally. Most CRCs arise from colorectal adenomas (CRAs), particularly advanced adenomas, which are recognized as critical precancerous lesions. Early detection and intervention at the adenoma stage are essential for alleviating the global disease burden of CRC. However, conventional screening methods such as colonoscopy are invasive and have poor compliance, underscoring the urgent need for efficient, noninvasive diagnostic alternatives. Blood-based biomarkers have gained substantial attention because of their accessibility, reproducibility, and potential for early detection. Advances in multiomics technologies including proteomics, metabolomics, transcriptomics, and epigenomics have led to the identification of numerous plasma-and serumderived biomarkers. These include noncoding RNAs (e.g., microRNAs, circular RNAs, PIWI-interacting RNAs), DNA methylation signatures, disease-specific proteins, and metabolic profiles. Moreover, emerging platforms such as liquid bio-  \n [https://dx.doi.org/10.3748/wjg.v32.i7.114538](https://dx.doi.org/10.3748/wjg.v32.i7.114538) 1 February 21, 2026  Volume 32  Issue 7   \nQi CY et al. Blood biomarkers for CRA  \npsy, extracellular vesicle profiling, and machine learning further expand the landscape of early CRA detection. The integration of multiomics data holds promise for substantially increasing the sensitivity and specificity of early adenoma detection, offering a transformative framework","cbCaig4wFqcfUq0l","https://ap.wps.com/l/cbCaig4wFqcfUq0l","pdf",1804080,16,"English","# Background and clinical need\n## Adenoma-carcinoma sequence and precancerous lesions\n## Limitations of conventional screening\n# Blood-based biomarkers and multiomics advances\n## Accessible and reproducible biomarker sources\n## Proteomics, metabolomics, transcriptomics, and epigenomics\n## Emerging platforms and data integration\n# Clinical promise\n## Improving sensitivity and specificity for early detection","[{\"question\":\"Why is early diagnosis of colorectal adenoma important?\",\"answer\":\"Most colorectal cancers develop through an adenoma-carcinoma sequence, beginning with colorectal adenomas. Detecting and intervening at the adenoma stage helps reduce the global burden of colorectal cancer.\"},{\"question\":\"What is the main limitation of conventional CRC screening methods mentioned in the document?\",\"answer\":\"Conventional screening such as colonoscopy is invasive and has poor compliance. This drives the urgent need for efficient, noninvasive diagnostic alternatives.\"},{\"question\":\"How do blood-based biomarkers support noninvasive screening?\",\"answer\":\"Blood-based biomarkers are highlighted for their accessibility and reproducibility, enabling early detection. Multiomics approaches identify many plasma- and serum-derived biomarker types that can enhance adenoma detection.\"}]","Noninvasive diagnosis of colorectal adenoma - The emerging potential of blood-based biomarkers | PDF",1790124966,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bf4cdbb41c9783859e1ed038b0d46b8.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/863fb6a3410cb5cdc2a487d2e1de5456.webp",982,1389,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24e4ce688c0ddbda4dc7d98e13c3fba4.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/651d736079575711fbb79dd42ae26f84.webp",980,1386]